Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

PIRS Stock Forecast, Price Targets, Chart, Dividends & Analysis

Pieris Pharmaceuticals Inc. logo

Pieris Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

16.70
 
USD
  
0.60
  
(3.73%)
Previous close: 16.1  Open: 16.2245  Bid: 16.2  Ask: 18.7
52 week range    
6.20   
   22.32
Mkt Cap: 21 M  Avg Vol (90 Days): 18,330
Peers   
IMUC / 
CSBR / 
AEZS / 
Last updated: Thursday 5th December 2024

Stock Rankings

63
MarketXLS Rank
60
Value
84
Technical
47
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

AEZS

0 B-25.72

CSBR

0 B-174.3

GILD

0.0328115 B1044.6791.59

IMUC

Financials

PIRS Income Statement

Annual
Invalid dateDec-20Dec-21Dec-22Dec-23
AcquiredInProcessRnD8 M
Basic EPS from continuing operations-0.68-0.71-0.45-0.27
Basic EPS total-0.68-0.71-0.45-0.27
Basic weighted shares outstanding54 M65 M74 M90 M
Depreciation2 M2 M2 M2 M
DepreciationAndAmortization2 M2 M2 M2 M
Diluted EPS total-0.68-0.71-0.45-0.27
Diluted normalized net income/share-0.71
Diluted weighted shares outstanding54 M65 M74 M90 M
GainOnSaleOfSecurity-600000.0400000.0-100000.0
GeneralAndAdministrativeExpense17 M17 M16 M17 M
Gross operating profit29 M31 M25 M42 M
ImpairmentOfCapitalAssets14 M
Income before tax-37 M-49 M-33 M-25 M
Income taxes164000.0
Interest income511000.04000.0721000.02 M
InterestIncomeOperating8 M
MiscOtherSpecialCharges2 M6 M2 M4 M
Net income from total operations-37 M-46 M-33 M-25 M
NetIncomeCommonStockholders-37 M-49 M-33 M-25 M
NetIncomeContinuousOperations-37 M-46 M-33 M-25 M
NetNonOperatingInterestIncomeExpense511000.04000.0721000.02 M
Normalized income-39 M
Operating income-34 M-52 M-44 M-16 M
Operating income before depreciation (EBITDA)-35 M-47 M-31 M-23 M
OperatingExpense63 M83 M69 M59 M
Other income net-2 M-6 M-2 M-4 M
OtherGandA17 M17 M16 M17 M
OtherOperatingExpenses2 M2 M2 M2 M
Research & development expense47 M67 M53 M42 M
ResearchExpense47 M67 M53 M42 M
Revenue per share100000.0
Selling Gen & administrative expense17 M17 M16 M17 M
Special income/charges8 M-14 M
Total Income available for interest expense (EBIT)-37 M-49 M-33 M-25 M
Total common shares outstanding60 M74 M75 M99 M
Total net income-37 M-46 M-33 M-25 M
Total ordinary shares1 M1 M1 M1 M
Total revenues24 M28 M25 M42 M
TotalExpenses63 M83 M69 M73 M
TotalRevenue29 M31 M25 M42 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University